2 Patents
- US125952582026Heterocyclic Derivatives, Pharmaceutical Compositions and Their Use in the Treatment or Amelioration of Cancer
Tolremo Therapeutics AG
0 cites - US124721792025Combination of a Cbp/p300 Bromodomain Inhibitor and a KRAS Inhibitor for the Treatment of Cancer
Tolremo Therapeutics AG
0 cites